摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Pent-1-yne;hydrochloride

分子结构分类

中文名称
——
中文别名
——
英文名称
Pent-1-yne;hydrochloride
英文别名
pent-1-yne;hydrochloride
Pent-1-yne;hydrochloride化学式
CAS
——
化学式
C5H9Cl
mdl
——
分子量
104.58
InChiKey
SWHANMVHZZGAON-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.84
  • 重原子数:
    6
  • 可旋转键数:
    1
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    0
  • 氢给体数:
    1
  • 氢受体数:
    0

文献信息

  • Sulfur(VI) fluoride compounds and methods for the preparation thereof
    申请人:The Scripps Research Institute
    公开号:US10117840B2
    公开(公告)日:2018-11-06
    This application describes a compound represented by Formula (I): (I) wherein: Y is a biologically active organic core group comprising one or more of an aryl group, a heteroaryl aryl group, a nonaromatic hydrocarbyl group, and a nonaromatic heterocyclic group, to which Z is covalently bonded; n is 1, 2, 3, 4 or 5; m is 1 or 2; Z is O, NR, or N; X1 is a covalent bond or —CH2CH2—, X2 is O or NR; and R comprises H or a substituted or unsubstituted group selected from an aryl group, a heteroaryl aryl group, a nonaromatic hydrocarbyl group, and a nonaromatic heterocyclic group. Methods of preparing the compounds, methods of using the compounds, and pharmaceutical compositions comprising the compounds are described as well.
    该应用描述了由式(I)表示的化合物:(I)其中:Y是一个生物活性有机核心基团,包括芳基、杂芳基、非芳香烃基和非芳香杂环基中的一个或多个,其中Z与之以共价键结合;n为1、2、3、4或5;m为1或2;Z为O、NR或N;X1为共价键或—CH2CH2—,X2为O或NR;R包括H或从芳基、杂芳基、非芳香烃基和非芳香杂环基中选择的取代或未取代基团。还描述了制备这些化合物的方法、使用这些化合物的方法以及包含这些化合物的药物组合物。
  • SULFUR (VI) FLUORIDE COMPOUNDS AND THEIR USE AS SCREENING AGENT
    申请人:The Scripps Research Institute
    公开号:EP3892610A1
    公开(公告)日:2021-10-13
    This application describes a compound represented by Formula (III): wherein: A is a biologically active organic core group comprising one or more of an aryl group, a heteroaryl aryl group, a nonaromatic hydrocarbyl group, and a nonaromatic heterocyclic group, to which Z is covalently bonded; n is 1, 2, 3, 4 or 5; m is 1 or 2; Z is O, NR, or N; X1 is a covalent bond or -CH2CH2-, and R comprises H or a substituted or unsubstituted group selected from an aryl group, a heteroaryl aryl group, a nonaromatic hydrocarbyl group, and a nonaromatic heterocyclic group. Methods of using the compounds as screening agent to identify drug targets, and pharmaceutical compositions comprising the compounds are described as well.
    本申请描述了一种由式 (III) 表示的化合物: 其中A 是生物活性有机核心基团,包括芳基、杂芳基、非芳香烃基和非芳香杂环基中的一个或多个,Z 与之共价键合;n 是 1、2、3、4 或 5;m为1或2;Z为O、NR或N;X1为共价键或-CH2CH2-,R包括H或一个取代或未取代的基团,该基团选自芳基、杂芳基、非芳香烃基和非芳香杂环基。 此外,还描述了将这些化合物用作筛选剂以确定药物靶点的方法,以及包含这些化合物的药物组合物。
  • Sulfur (VI) fluoride compounds and methods for the preparation thereof
    申请人:THE SCRIPPS RESEARCH INSTITUTE
    公开号:US11141385B2
    公开(公告)日:2021-10-12
    This application describes a compound represented by Formula (I): wherein: Y is a biologically active organic core group comprising one or more of an aryl group, a heteroaryl aryl group, a nonaromatic hydrocarbyl group, and a nonaromatic heterocyclic group, to which Z is covalently bonded; n is 1, 2, 3, 4 or 5; m is 1 or 2; Z is O, NR, or N; X1 is a covalent bond or —CH2CH2—, X2 is O or NR; and R comprises H or a substituted or unsubstituted group selected from an aryl group, a heteroaryl aryl group, a nonaromatic hydrocarbyl group, and a nonaromatic heterocyclic group. Methods of preparing the compounds, methods of using the compounds, and pharmaceutical compositions comprising the compounds are described as well.
    本申请描述了一种由式 (I) 表示的化合物: 其中Y 是生物活性有机核心基团,包括芳基、杂芳基、非芳香烃基和非芳香杂环基中的一个或多个,Z 与之共价键合;n 是 1、2、3、4 或 5;m 是 1 或 2;Z是O、NR或N;X1是共价键或-CH2CH2-,X2是O或NR;R包括H或选自芳基、杂芳基、非芳香烃基和非芳香杂环基的取代或未取代基团。此外,还描述了制备这些化合物的方法、使用这些化合物的方法以及包含这些化合物的药物组合物。
  • N-PROP-2-YNYL CARBOXAMIDE DERIVATIVES AND THEIR USE AS TRPA1 ANTAGONISTS
    申请人:Orion Corporation
    公开号:EP2903965A1
    公开(公告)日:2015-08-12
  • SULFUR(VI) FLUORIDE COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF
    申请人:The Scripps Research Institute
    公开号:EP3151817B1
    公开(公告)日:2021-03-03
查看更多

同类化合物

锡烷,三丁基(5,5-二甲基-1,3-己二炔基)- 甲基D1乙炔 溴化氢-乙炔络合物 氯(己-5-炔基)甲基硅烷 戊-4-炔-1-胺盐酸盐 庚-1,2,4-三烯-6-炔 四(3,3,3-三氟丙-1-炔基)锡烷 乙炔基甲基硅烷 乙炔基三氟硅烷 乙炔基(二甲基)硅烷 乙炔化汞 [1-13C]-叔丁基乙炔 S-2-丙炔-1-基甲烷硫代磺酸酯 7-溴-5-甲基庚-5-烯-1-炔 5-己炔胺盐酸盐 4-乙炔基环己烷甲醛 2-氰基乙炔基(环己基)汞 2-(丙-2-炔-1-基)戊-4-炔-1-醇 1-锂-3-甲基-1,2-丁二烯 1-癸炔-1,2-13C2 1-氯-3-乙炔基-2-甲基辛-2-烯 1-乙炔基环丙胺盐酸盐 1-乙炔-1-甲基-环己烷 1,7,13,19-二十四炔 1,1-二氯-2-乙炔基环丁烷 (己-5-炔基)二甲基硅烷 (S)-3-丁炔-2-胺 (R)-1-甲基-2-丙炔胺 (4-环丙基-3,4-二甲基己-1,5-二炔-3-基)环丙烷 (4-乙炔基环己基)甲醇 (1-乙炔基环丙基)甲醇 ((1-氯环丙基)乙炔基)锂 ethyl 4-[4-(tri-n-butylstannyl)-2-methyl-2-buten-1-yloxy]-2-butynoate (E)-1-bromo-6-methyl-2-octen-4-yne (Z)-1-bromo-6-methyl-2-octen-4-yne chloro-2 ureidoxy-1 butane 1,11-dimethyl-3,6,9,13,16,19,22,25,28-nonaoxa-bicyclo[9.9.9]nonacosane cis-3,7-dicyano-1-(methylene)bicyclo<4.3.0>nonane 2,2,3,3,4,4,5,5,6,6,7,7,8,8,10-pentadecadeuteriodec-9-yn-1-ol 1,1,1,3,3,3-hexaethyltrigermane 1,3,11,13-tetraaza-cycloeicosane-2,12-dithione tris(tris(dimethylsilyl)methyl)yttrium dodecacarbonyl[μ4-(η,η,η,η)(trideca-1,12-diene-5,8-diyne)]tetracobalt 4-Pentynylhydrazine (4R,5R)-2-((S)-1-Chloro-propyl)-4,5-dicyclohexyl-[1,3,2]dioxaborolane (Z)-7-Bromo-6-methyl-hept-5-en-1-yne (1S)-1-chloro-2-methylidenecyclononane;chloropalladium(1+)